National patterns of riskstandardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia. Novel intravenous treatment for acute heart failure. Hospitals and physician groups stand at the beginning of a new era of improving heart failure patient outcomes while reducing costs. Assessing acute decompensated heart failure strategies. The failure of current strategies may be due to advanced disease in hospitalized. Improving care for patients with acute heart failure. Increased funding is needed for research into new and more effective. Heart failure therapies in the acute setting cardiac. Can blood volume analysisguided acute heart failure.
Heart failure hf is the leading cause of hospitalization among patients over the age of 65 in the united states and developed countries, posing a significant economic burden to the health care systems. Acute heart failure an overview sciencedirect topics. Most patients with acute decompensated heart failure adhf are admitted for symptomatic treatment of congestion with intravenous diuretics and to a much lesser degree for respiratory failure, cardiogenic shock, incessant ventricular tachycardia, or the need for urgent diagnostic or therapeutic procedures 6,20,21,3140. New strategies for improving outcomes pharmacology cme acute decompensated heart failure is a common emergency department presentation with significant associated morbidity and mortality.
Goals of acute management rapidly improve symptoms while preserving end organ function. The study was a retrospective analysis of the acute decompensated heart failure national registry adhere. Acute heart failure ahf is generally defined as the rapid development or change of symptoms and signs of heart failure that requires urgent medical attention 1. In patients with clinical evidence of hypotension associated with hypoperfusion and obvious evidence of elevated cardiac filling pressures e. These strategies were assessed recently by felker et al in the dose diuretic optimization. Diuretic strategies in patients with acute decompensated heart failure dose study felker gm, lee kl, bull da, et. Acute decompensated heart failure an overview sciencedirect. Overall, ahf is a prevalent condition, as it represents the first reason for hospitalization in advanced age. Therapeutic strategies for heart failure in cardiorenal. Acute decompensated heart failure adhf is a clinical syndrome of worsening signs or symptoms of heart failure hf requiring hospitalization or other unscheduled medical care. There have been several trials exploring advanced intravenous therapy in addition to diuretics, nitrates and vasopressors in order to improve symptoms and outcomes in heart failure but widespread use has been limited due to safety concerns and lack of robust evidence. House, md, msc,1 mikko haapio, md,2 johan lassus, md,3 rinaldo bellomo, md,4 and claudio ronco, md5,6 cardiorenal syndromes are disorders of the heart and kidneys whereby acute or longterm dysfunction in one organ may induce acute or longterm dysfunction of the other. However, options for the management of these patients remain crude and limited.
More than half of the patients with hf will be readmitted to the hospital within 6 months from discharge, leading not only to increased health care related expenses but. Acute heart failure is usually defined as the rapid onset of, or change in, signs andor symptoms of heart failure resulting in the need for urgent treatment. Acute decompensated heart failure adhf occurs when cardiac output fails to meet the bodys metabolic needs. In a prospective, doubleblind, randomized trial, we assigned 308 patients with acute decompensated heart failure to receive furosemide administered intravenously by means of either a bolus every 12 hours or continuous infusion and at either a low dose equivalent to the patients previous oral dose or a high dose. Diuretic strategies in patients with acute decompensated. Despite substantial improvement in outcomes for patients with chronic heart failure hf. Emerging heart failure strategies improve outcomes and. The goals in the treatment of heart failure are to improve clinical symptoms and outcomes management strategy should be based on clinical, laboratory and. Effect of nesiritide in patients with acute decompensated heart failure.
In this capacity, if a drug could improve outcomes in refractory acute decompensated heart failure and had an impact on worsening inhospital heart failure and length of stay without increasing 30day events, it would be a success. Clinical congestion is the most dominant feature in patients with acute decompensated heart failure hf. Strategies evaluation trial in acute heart failure dose hf, the cardiorenal rescue study in acute heart failure carress hf, and the renal optimization strategies evaluation trial in acute heart failure rose hf. Emerging heart failure strategies improve outcomes and reduce. To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization days alive and outside the hospital compared to usual care. A rational approach for the treatment of acute heart. Managing acute decompensated heart failure american nurse. Other causes of ahfs include new onset heart failure due to an acute coronary event, such as a myocardial infarction mi, and endstage or refractory heart failure that is not responsive to therapy.
Hospital strategies associated with 30day readmission rates for patients with heart failure. A new approach to treatment of acute heart failure sciencedirect. Sometimes termed fluid volume overload, this unstable condition requires immediate treatment because it impairs perfusion to systemic organs, jeopardizing their function. Acute decompensated heart failure adhf is a complex clinical event associated with excess morbidity and mortality. Recent findings recent data have confirmed the heterogeneous nature of patients admitted with acute decompensated heart failure, and the limitations of the current therapeutic regimens with diuretics, intravenous vasodilators ie, nitroglycerin. A study was undertaken to compare the outcomes of patients who did and did not receive morphine for adhf. Hospitalization for acute heart failure syndromes ahfs is a significant negative predictor of prognosis. Included as part of the 4 credits, this cme activity. Acute heart failure represents the first cause of hospitalization in elderly persons and is the main determinant of the huge healthcare expenditure related to heart failure. A more recent term, acute heart failure syndromes, is defined more broadly as new onset or gradual or rapidly worsening hf that requires urgent therapy. Payment agencies, such as centers for medicare and medicaid services and private sector insurance, would.
For many years, adhf was viewed as simply an exacerbation. Acute decompensated heart failure adhf is the leading cause of hospital admissions in patients older than 65 years. Evaluation and management of patients with acute decompensated heart failure overview acute decompensated heart failure adhf has emerged as a major public health problem over the past 2 decades. It is a growing problem, and the prognosis for patients with ahfs remains poor. A table to assist with emergency management of adhf is provided table 1. Objective there are conflicting results among previous studies regarding the prognosis of heart failure with preserved ejection fraction hfpef compared with heart failure with reduced ejection fraction hfref. Conceptual considerations for devicebased therapy in. Cardiology and cardiovascular sciences, federal university of rio grande do sul, porto alegre, rs, brazil. Symptoms typical of heart failure breathlessness at rest or on exercise, fatigue, tiredness, ankle swelling. Subcutaneous furosemide in acute decompensated heart failure. Acute decompensated heart failure is a common emergency department presentation with significant associated morbidity and mortality. Heart failure accounts for more than 1 million hospitalizations annually, with a steadily increasing incidence as our population ages. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure. It is often a potentially lifethreatening condition, requiring hospitalisation, and emergency treatment is aimed predominantly at.
Definition of heart failure, from 2008 esc guidelines for the diagnosis and treatment of acute and chronic heart failure heart failure is a clinical syndrome in which patients have the following features. Each year about 550,000 new patients are diagnosed as having congestive heart failure, which for acutely symptomatic patients is also referred to as acutely decompensated heart failure. Patients presenting to the hospital with acute decompensated heart failure adhf can be categorized into four hemodynamic subsets based on volume status euvolemic or dry vs volume overloaded or wet and cardiac output adequate cardiac output or warm vs hypoperfusion or cold. Among patients with acute decompensated heart failure, there were no significant differences in patients global assessment of symptoms or in the change in renal function when diuretic therapy was administered by bolus as compared with continuous infusion or at a high dose as compared with a low dose. Patients with adhf represent a heterogeneous population with high postdischarge readmission rates 1. The management of adhf is drastically different from that of chronic heart failure as inpatient treatment consists. The incidence of congestive heart failure is approximately. Acute decompensated heart failure new presentation or decompensation. Acute heart failure is broadly defined as a rapid onset of new or worsening signs and symptoms of hf. To provide optimal care for patients with acute decompensated heart failure adhf, insights into the degrees of congestion is key.
Once the patient is stabilized and the acute hemodynamic abnormalities are reversed, the goal shifts to m. Morphine is a longstanding therapy in acute decompensated heart failure adhf, despite few supporting data. Heart failure therapy the clinical goal when managing acutely decompensated heart failure is to rapidly relieve symptoms by reversing the acute hemo\. These hospitalisations are highly risky and are associated with poor outcomes, including rehospitalisation and death. Despite therapeutic advances, the prognosis of acute heart failure is poor, with inhospital mortality ranging from 4% to 7%, 60 to 90day mortality ranging from 7% to 11%. The routine use of vasodilators does not improve outcomes, and should be avoided 14.
Strategies for management of acute decompensated heart failure. Acute decompensated heart failure adhf is a sudden worsening of the signs and symptoms of heart failure, which typically includes difficulty breathing, leg or feet swelling, and fatigue. Efficacy of rapid decongestion strategy in patients. Although patients presenting symptoms generally improve throughout hospitalization in response to therapy, postdischarge event rates, defined as rehospitalization andor mortality, remain unacceptably high. Morphine and outcomes in acute decompensated heart failure. Esc guidelines on the diagnosis and treatment of acute heart failureesc guidelines on the diagnosis and treatment of acute heart failure 29. Neither traditional therapies nor attempts at novel therapies definitively improve outcomes. The condition is caused by severe congestion of multiple organs by fluid that is inadequately circulated by the failing heart. Acute decompensated heart failure adhf is a clinical syndrome of new or worsening signs and symptoms of hf, often leading to hospitalization or a visit to the emergency department. Adhf is a common and potentially serious cause of acute respiratory distress. Acute heart failure ahf is defined as new onset or worsening of symptoms and signs of heart failure.
Adhere, acute decompensated heart failure national registry. Managing adhf patients is challenging because of the lack of effective treatments that both reduce symptoms and improve clinical outcomes. Inpatient management of acute decompensated heart failure. Heart failure model of care irelands health service. However, however, uncertainty exists due to the permutations and combinations of congestion status and decongestion strategies. Therapeutic strategies for heart failure in cardiorenal syndromes andrew a. Home hospitalization for acute decompensated heart failure. New strategies for improving outcomes pharmacology cme. Subcutaneous furosemide in acute decompensated heart. Acute decompensated heart failure adhf is a common and. Approach to general management patients presenting with acute dyspnea from acute decompensated heart failure adhf should be rapidly assessed and stabilized. Acute decompensated heart failure has been defined as hf with a relatively rapid onset of signs and symptoms, resulting in hospitalization or unplanned office or emergency department visits. Acute decompensated heart failure adhf is a syndrome defined by worsening fatigue, dyspnea, or edema that results from deteriorating heart function and usually leads to hospital admission or unscheduled medical intervention.
195 818 331 216 479 436 1404 480 578 1404 973 270 422 868 1341 681 69 35 206 991 230 1632 165 187 1528 379 871 282 1324 1292 1308 651 991 1047 783 678 1203 588 1078 192